Effect of lithium on hepatic drug-metabolizing enzymes of protein-deficient rats

被引:0
|
作者
Aparna Tandon
J. P. Nagpaul
D. K. Dhawan
机构
[1] Panjab University,Department of Biochemistry
[2] Panjab University,Department of Biophysics
来源
Biological Trace Element Research | 1997年 / 59卷
关键词
Lithium; low protein diet; drug-metabolizing enzymes;
D O I
暂无
中图分类号
学科分类号
摘要
Protein deficiency was produced by feeding synthetic 8%-protein diet. Lithium carbonate at the dose level of 1.1g/kg diet was administered to normal and protein-deficient rats for a period of one mo. A significant inhibition in the levels of cytochrome (cyt) P450, cyt b5, glutathione (GSH), glutathione S-transferase (GST) and glutathione peroxidase (GPx), but an increase in γ-glutamyl transpeptidase (γ-GT), was observed in low-protein LP-fed rats. Lithium treatment to normal rats caused no significant change in the activities of cyt P450, cyt b5, GST, and GSH levels, whereas there was elevation in the activities of γ-GT and GPx and suppression in glutathione reductase (GRd) activity. Lithium administration to LP-fed rats resulted in significant increases in the hepatic γ-GT and GPx activities.
引用
收藏
页码:159 / 165
页数:6
相关论文
共 50 条
  • [41] The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure
    Zhang, Mengxu
    Rottschafer, Vivi
    de Lange, Elizabeth C. M.
    DRUG METABOLISM REVIEWS, 2024, 56 (01) : 1 - 30
  • [42] An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: Experience in Singapore
    Chowbay, B
    Zhou, SF
    Lee, EJD
    DRUG METABOLISM REVIEWS, 2005, 37 (02) : 327 - 378
  • [43] EFFECT OF FLAVONOIDS OVER LIPIDS IN RATS AND OVER DRUG-METABOLIZING-ENZYMES
    NAGEM, TJ
    ALBUQUERQUE, TTDE
    DEMIRANDA, LCG
    PEREIRA, CAD
    ARQUIVOS DE BIOLOGIA E TECNOLOGIA, 1994, 37 (03): : 471 - 482
  • [44] Hepatic Drug-Metabolizing Enzyme Induction and Implications for Preclinical and Clinical Risk Assessment
    Mohutsky, Michael A.
    Romeike, Annette
    Meador, Vince
    Lee, William M.
    Fowler, John
    Francke-Carroll, Sabine
    TOXICOLOGIC PATHOLOGY, 2010, 38 (05) : 799 - 809
  • [45] Influence of 50-Hz sinusoidal electromagnetic field on hepatic and pulmonary phase I and II drug-metabolizing enzymes in mice
    Singh, S
    Khanduja, KL
    Mittal, PK
    ELECTRO- AND MAGNETOBIOLOGY, 1998, 17 (03): : 343 - 350
  • [46] Does Hepatic Steatosis Affect Drug Metabolizing Enzymes in the Liver?
    Buechler, Christa
    Weiss, Thomas S.
    CURRENT DRUG METABOLISM, 2011, 12 (01) : 24 - 34
  • [47] EFFECT OF LONG-TERM IRON-DEFICIENCY ON THE ACTIVITIES OF HEPATIC AND EXTRAHEPATIC DRUG-METABOLIZING-ENZYMES IN FISCHER RATS
    RAO, NJ
    JAGADEESAN, V
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1995, 110 (01): : 167 - 173
  • [48] The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia
    Bolufer, Pascual
    Collado, Maria
    Barragan, Eva
    Cervera, Jose
    Calasanz, Maria-Jose
    Colomer, Dolors
    Roman-Gomez, Jose
    Sanz, Miguel A.
    HAEMATOLOGICA, 2007, 92 (03) : 308 - 314
  • [49] Molecular mechanism of phase I and phase II drug-metabolizing enzymes: Implications for detoxification
    Iyanagi, Takashi
    INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 260, 2007, 260 : 35 - 112
  • [50] Chronic Toxoplasma infection affects gene expression of drug-metabolizing enzymes in mouse liver
    Uno, Yasuhiro
    Uehara, Shotaro
    Ushirozako, Genki
    Masatani, Tatsunori
    Yamazaki, Hiroshi
    XENOBIOTICA, 2023, 53 (10-11) : 581 - 586